Skip NavigationSkip to Content
Return Return to Search Results

A potential mechanism for fumonisin B-1-mediated hepatocarcinogenesis: cyclin D1 stabilization associated with activation of Akt and inhibition of GSK-3 beta activity

  1. Author:
    Ramljak, D.
    Calvert, R. J.
    Wiesenfeld, P. W.
    Diwan, B. A.
    Catipovic, B.
    Marasas, W. F. O.
    Victor, T. C.
    Anderson, L. M.
    Gelderblom, W. C. A.

  2. Author Address

    Ramljak D NCI, Comparat Carcinogenesis Lab, Frederick Canc Res & Dev Ctr Bldg 538,Room 205E Frederick, MD 21702 USA NCI, Comparat Carcinogenesis Lab, Frederick Canc Res & Dev Ctr Frederick, MD 21702 USA US FDA, Ctr Food Safety & Appl Nutr, Off Special Nutr, Div Sci & Appl Technol Laurel, MD 20708 USA NCI, Intramural Res Support Program, SAIC Frederick, Frederick Canc Res & Dev Ctr Frederick, MD 21702 USA Johns Hopkins Univ, Ctr Asthma & Allergy Baltimore, MD 21224 USA S African MRC, Nutr Dis Res Inst ZA-7505 Tygerberg South Africa Univ Stellenbosch, MRC, Ctr Cellular & Mol Biol ZA-7505 Tygerberg South Africa
    1. Year: 2000
  2. Journal: Carcinogenesis
    1. 21
    2. 8
    3. Pages: 1537-1546
  4. Type of Article: Article
  1. Abstract:

    Fumonisin B-1 (FB1) is a worldwide corn contaminant and has been epidemiologically linked to the high incidence of human esophageal cancer in South Africa and China. FB1 is hepatocarcinogenic in rats by an unknown mechanism. Inhibition of ceramide synthase and disruption of membrane phospholipids have been shown to be mechanisms of toxicity. Here we show overexpression of cyclin D1 protein in both preneoplastic and neoplastic liver specimens obtained from a long-term feeding study of FB1 in rats. In rats fed FB1 short-term, cyclin D1 protein levels in liver were increased up to five-fold in a dose-responsive manner. Northern blot analysis demonstrated no increase in mRNA levels of cyclin D1, 2D electrophoresis of cyclin D1 protein in FB1-treated samples showed a distinct pattern of migration (presence of less negatively charged form of the protein) that differed from controls. Recently, it has been shown that phosphorylation of cyclin D1 by glycogen synthase kinase 3 beta (GSK-3 beta) on a single threonine residue (Thr-286) positively regulates proteosomal degradation of cyclin D1, In FB1-treated samples we detected GSK-3 beta phosphorylated on serine 9; activated protein kinase B (Akt) appears to be responsible for this activity-inhibiting phosphorylation, These findings suggest that overexpression of cyclin D1 results from stabilization due to a lack of phosphorylation mediated by GSK-3 beta, We also observed an increase in cyclin dependent kinase 4 (Cdk4) complexes with cyclin D1 in FB1-treated samples; additionally, elevated Cdk4 activity was shown by increased phosphorylation of the retinoblastoma protein. In summary, the activation of Akt leads to increased survival, inhibition of GSK-3 beta activity and post-translational stabilization of cyclin D1, all events responsible for disruption of the cell cycle G(1)/S restriction point in hepatocytes, This is the first report suggesting the mechanism by which FB1 acts as a carcinogen. [References: 59]

    See More

  1. Keywords:

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel